Clinical Trials in New York

Showing 9821-9840 of 22,668 trials

Rapid Diagnostics for HIV and Hepatitis

NCT02190305

The purpose of this study is to determine the efficacy of two rapid diagnostic tests in plasma, venipuncture whole blood, and fingerstick whole blood. The clinical performance of Multiplo HBc/HIV/HCV will be determined by comparing the results with patient infected status for HIV-1/2 (human immunodeficiency viruses 1 and 2), HBV (hepatitis B virus) and HCV (hepatitis C virus). The clinical performance of Reveal HBsAg will be determined by comparing the results with patient infected status for HBV. Subject participation in the study will consist of a single one-hour visit, at which time blood samples will be drawn for testing with the investigational devices and with approved comparator assays. The test results, which are the outcome of the study, will be obtained only once, at the time of this visit.

HIV InfectionsHepatitis B InfectionsHepatitis C Infections

MedMira Laboratories Inc.Started May 2014

Los Angeles, California, United States • Miami, Florida, United States • Minneapolis, Minnesota, United States +1 more locations

No Longer Available< 1 mile

Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)

NCT03433807

The primary objective of this Expanded Access Program is to provide idebenone as a treatment for eligible participants with Duchenne Muscular Dystrophy before it is commercially available in the United States (U.S.) for the indication of DMD.

Duchenne Muscular Dystrophy

Santhera Pharmaceuticals

Phoenix, Arizona, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +9 more locations

Rapid Diagnostics for HIV and Hepatitis

Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)

Find Trials by Condition in New York

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy

A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis

tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden

Brief Intervention for OCD Fears

PET Imaging of Subjects Using 124I-PU-AD

Genomic Response Analysis of Heart Failure Therapy in African Americans

Minimally Invasive Treatment of Primary Great Saphenous Vein (GSV) Insufficiency Using High Intensity Focused Ultrasound (HIFU)

VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis

A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery

Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)

A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations

Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)